Historical record - last NADAC publication: 3/23/2022
Product Information
MORPHINE SULF ER 30 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3462 per EA under NDC 43386054101. Its NADAC has been published 265 times since Mar 15, 2017.
Strength
30 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386054101
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
3/23/2022
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA203602On Market Since
12/16/2015
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULF ER 30 MG TABLET has been published 265 times since Mar 15, 2017, and over the history we have for it it has declined 38.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3462 per EA |
|---|---|
| All-time high | $0.5603 (Mar 15, 2017) |
| All-time low | $0.2713 (Nov 20, 2019) |
| Median price | $0.3567 |
| Average price | $0.3636 |
| Largest weekly change | +27.0% (Jan 22, 2020) |
| Weeks tracked | 265 |
| Tracking since | Mar 15, 2017 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MORPHINE SULF ER 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULF ER 30 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.3462 per EA (NDC 43386054101), effective Apr 6, 2022.
How has the price of MORPHINE SULF ER 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for MORPHINE SULF ER 30 MG TABLET has declined 38.2%. It has been tracked across 265 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for MORPHINE SULF ER 30 MG TABLET?
Since Mar 15, 2017, the NADAC for MORPHINE SULF ER 30 MG TABLET has ranged from a low of $0.2713 (Nov 20, 2019) to a high of $0.5603 (Mar 15, 2017), with a median of $0.3567 per EA.
Are there cheaper alternatives to MORPHINE SULF ER 30 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as MORPHINE SULF ER 30 MG TABLET, but none are currently priced below it.
Who manufactures MORPHINE SULF ER 30 MG TABLET?
MORPHINE SULF ER 30 MG TABLET (NDC 43386054101) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification